Reaction Pathways for Synthesis of Pharmaceutical Intermediates is a specialized chemical product identifiable by its CAS number {cas_number}. Its molecular structure is described by the formula {molecular_formula}, and the compound possesses a molecular weight of {molecular_weight}. For unambiguous identification by researchers and manufacturers alike, the IUPAC name is {iupac_name} and its unique InChIKey is {inchikey}. This compound is classified as a pharmaceutical intermediate, serving a critical role in the multi-step synthesis of active pharmaceutical ingredients.
In terms of its physical and chemical attributes, the product has been characterized with key specifications relevant for handling and application in industrial and laboratory settings. {If melting_point is not empty: Its melting point provides insight into temperature requirements for storage and processing.} {If boiling_point is not empty: The boiling point offers additional guidance for reactions conducted under heat.} {If density is not empty: Density is an essential consideration for solvent compatibility and phase transfer processes.} {If flash_point is not empty: The flash point of the material informs on fire safety protocols.} {If vapor_pressure is not empty: Vapor pressure values impact storage and environmental exposure considerations.} Each of these parameters helps ensure optimal conditions are maintained during manufacturing and application.
From a regulatory and compliance standpoint, Reaction Pathways for Synthesis of Pharmaceutical Intermediates meets several key industry requirements. {If reach_json is not empty: It holds REACH registration in accordance with the applicable article and tonnage band.} {If tsca_json is not empty: This intermediate is listed on the TSCA Inventory with reference to the appropriate section, confirming its eligibility for use in the United States.} {If ich_json is not empty: All relevant ICH guidelines, including the specific revision and any numerical or qualitative limitation, apply to its synthesis and usage.} {If ghs_json is not empty: The product aligns with the GHS hazard classification system, with full H-phrase statements and any required signal words provided for proper hazard communication.} {If pharma_json is not empty: Pharmacopeial standards are documented with reference to applicable chapters, ensuring compliance for pharmaceutical applications.} {If osha_pel is not empty: Occupational exposure limits, such as OSHA's PEL, are cited to help facilities maintain a safe work environment.} {If niosh_rel is not empty: Likewise, NIOSH's REL is available for additional occupational health guidance.}
This intermediate is leveraged extensively in the chemical synthesis of pharmaceutical compounds, acting as a key building block within established synthetic pathways. Its predominant use is as an intermediate step leading to various active ingredients, facilitating crucial functional group transformations and making it an essential component in multi-step organic synthesis. Its application spans a spectrum of reactions relevant to the preparation of target drugs, as documented in reference synthesis routes indexed in major chemical and pharmaceutical databases. However, the compound itself is not administered therapeutically.
For ease of integration into manufacturing workflows, Reaction Pathways for Synthesis of Pharmaceutical Intermediates is offered in standard industry packaging formats, such as 25-kilogram drums, 200-kilogram drums, or intermediate bulk containers, depending on customer requirements and order scale. Storage should be executed in accordance with stability data derived from GHS guidelines, favoring a cool, dry, and well-ventilated area away from incompatible substances. As with most pharmaceutical intermediates, a shelf life of two to three years is generally advised when optimal storage conditions are maintained, though users should always consult lot-specific certificates for confirmation.
Sources for this information include the PubChem Compound Database, the NIST Chemistry WebBook, the European Chemicals Agency portal, and the United States Environmental Protection Agency’s TSCA Chemical Substance Inventory. For comprehensive regulatory details and product-specific updates, users are encouraged to consult these resources directly at https://pubchem.ncbi.nlm.nih.gov/compound/{cid}, https://webbook.nist.gov/cgi/cbook.cgi?Name={cas_number}, {echa_url}, and https://www.epa.gov/tsca-inventory.
Related Articles
